Skip to content

Effect of Early Transition to Assisted Ventilation on 28-day Successful Extubation in Critically Ill Patients

Effect of Early Transition to Assisted Ventilation on 28-day Successful Extubation in Critically Ill Patients: A Multicenter Open-label Randomized Controlled Trial (EARLY-VENT)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07519512
Acronym
EARLY-VENT
Enrollment
1600
Registered
2026-04-09
Start date
2026-08-01
Completion date
2030-12-31
Last updated
2026-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mechanical Ventilator Care

Brief summary

EARLY-VENT is a multicenter, open-label, three-period cluster-randomized crossover trial designed to evaluate whether early transition from controlled to assisted ventilation improves outcomes in critically ill patients. The study will enroll approximately 1,600 adult patients across 10 ICUs who are expected to require mechanical ventilation for at least 48 hours and meet specific stability criteria (e.g., hemodynamically stable, light sedation). Participating centers will alternate between an experimental strategy, where patients transition to an assisted mode (preferably Pressure Support Ventilation) within 6 hours of eligibility, and a control strategy based on standard care practices. The primary endpoint is the rate of successful extubation at day 28, aiming to demonstrate that transition from controlled to assisted ventilation can reduce ventilation duration and improve prognosis compared to delayed transition.

Interventions

BEHAVIORALEarly Transition

Patients are transitioned from controlled to assisted ventilation (preferably Pressure Support Ventilation) within 6 hours of meeting the eligibility criteria

Sponsors

Southeast University, China
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years. * Expected ICU stay and mechanical ventilation (MV) ≥ 48 hours. * Currently receiving controlled ventilation mode * No neuromuscular blocking agents in use, and sedation level RASS ≥ -3. * P/F ≥ 150 mmHg.

Exclusion criteria

* Severe end-stage irreversible respiratory, cardiac, or neurologic disease that may lead to long-term/chronic ventilator dependence or inability to wean from MV (e.g., interstitial lung disease/pulmonary fibrosis, cardiomyopathy, valvular disease, severe traumatic brain injury, Guillain-Barré syndrome, amyotrophic lateral sclerosis, multiple sclerosis, high cervical spinal cord injury, or other restrictive diseases). * Expected death or transfer out of the ICU within 48 hours. * Hemodynamic instability judged by the treating clinician. * Pregnancy. * Currently participating in other clinical studies related to mechanical ventilation. * Any other condition considered unsuitable for participation by the investigator. Written informed consent not obtained.

Design outcomes

Primary

MeasureTime frameDescription
the rate of successful extubation at day 28the rate of successful extubation at day 281. No re-intubation or death occurred for 7 consecutive days after extubation, or the patient survived ICU admission with non-invasive mechanical ventilation within 7 days post-extubation-whichever occurs first. 2. For tracheostomy patients: Successful extubation is defined as achieving spontaneous ventilation through the tracheostomy for seven consecutive days without any form of assisted ventilation, or discharge from the ICU without assisted respiratory support, whichever occurs first.

Countries

China

Contacts

CONTACTJie Wu
1010966339@qq.com+8615996317013

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 24, 2026